BOZEMAN, Mont. – FirmTech announced on March 6, 2024, that Dr. John P. Mulhall has joined its Scientific Advisory Board. Dr. Mulhall is the Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan Kettering Cancer Center in New York City.
New Board Member's Background
Dr. Mulhall, a world-renowned leader in men's sexual health, brings decades of experience and leadership in men’s sexual health care to FirmTech. He is also the current editor-in-chief of The Journal of Sexual Medicine and serves on the Board of Directors of the Sexual Medicine Society of North America (SMSNA).
His involvement in research includes more than 370 papers published in peer-reviewed journals, 58 book chapters, and 10 books to date. Dr. Mulhall holds multiple medical qualifications, including MD, MSc, FECSM, FACS, and FRCSI.
FirmTech stated that Dr. Mulhall will partner with colleagues to provide independent guidance, analysis of sextech data, and evaluation of FirmTech product offerings. This collaboration aims to ensure that products are science-backed and effective for men and women seeking to improve their sexual performance and health.
Focus on Wearable Technology and Post-Prostate Cancer Care
Dr. Mulhall expressed his excitement to join FirmTech’s independent scientific advisory board, stating that "Wearable technology is the wave of the future for sexual wellness." He emphasized his commitment to driving science-backed innovation.
As a physician who works with men with cancer, Dr. Mulhall noted the potential of FirmTech products to "revolutionize how we treat men post-prostate cancer surgery." He believes that new wearable technology developments, supported by the advisory board's work, "could positively impact tens of thousands of lives every year."
Elliot Justin, FirmTech CEO and founder, highlighted the importance of the advisory board in objectively assessing FirmTech product offerings and delivering helpful research data and devices to practitioners. Justin pointed out that men seek health care at a rate 40 to 60 percent less than women. He also noted that men with erectile dysfunction (ED) are 30 to 40 percent more likely to experience a heart attack within the next five years.
The Scientific Advisory Board
FirmTech's Scientific Advisory Board comprises members from both academia and private practice. In addition to Dr. Mulhall, the board includes Dr. Jim Hotaling, Dr. Philip J. Cheng, Dr. Ashley Winter, Dr. Ashley Tapscott, Dr. Amy Pearlman, Dr. Stanley Lewis, and Dr. Robert J. Valenzuela.
The board's collective expertise is intended to provide independent guidance and evaluation of FirmTech's product offerings. The goal is to ensure that these offerings are supported by scientific evidence and are effective for individuals seeking to enhance their sexual performance and health.
Key Facts
- Dr. John P. Mulhall joined FirmTech's Scientific Advisory Board on March 6, 2024.
- Dr. Mulhall is the Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan Kettering Cancer Center in New York City.
- He is the current editor-in-chief of The Journal of Sexual Medicine and serves on the Board of Directors of the Sexual Medicine Society of North America (SMSNA).
- Dr. Mulhall has published over 370 papers in peer-reviewed journals, 58 book chapters, and 10 books.
- FirmTech CEO and founder Elliot Justin noted that men seek health care at a rate 40 to 60 percent less than women.
- Men with erectile dysfunction are 30 to 40 percent more likely to have a heart attack in the next five years.
- Other members of the board include Dr. Jim Hotaling, Dr. Philip J. Cheng, Dr. Ashley Winter, Dr. Ashley Tapscott, Dr. Amy Pearlman, Dr. Stanley Lewis, and Dr. Robert J. Valenzuela.
